| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |